Nantahala Capital Management, LLC Syndax Pharmaceuticals Inc Call Options Transaction History

Nantahala Capital Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $2.9 Million - $4.35 Million	200,000 New	200,000 $2.9 Million
Q3 2022 Nov 10, 2022	BUY	$18.51 - $24.79 $555,300 - $743,700	30,000 New	30,000 $721,000
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $3.05 Million - $4.49 Million	200,000 New	200,000 $4.38 Million

227

95.1M

759K

635K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $844M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.